Tech Company Financing Transactions
Zegenex Funding Round
Richard King Mellon Foundation invested in a $215 thousand capital raise for Zegenex. The funding round closed on 12/11/2025.
Transaction Overview
Company Name
Announced On
12/11/2025
Transaction Type
Venture Equity
Amount
$215,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will support formulation optimization and preclinical testing of Zegen-15, a small-molecule cream designed to treat chronic wounds, beginning with Diabetic Foot Ulcers (DFUs).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Pittsburgh, PA Undisclosed
USA
Pittsburgh, PA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Zegenex, we are on track to transform wound care with our innovative medicated healing devices. Whether it's a laceration, burn, or diabetic foot ulcer, our advanced technology ensures faster healing and reduced scarring, giving you the confidence to live life to the fullest.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Manush Saydmohammed
Browse more venture capital transactions:
Prev: 12/11/2025: Steelhead Technologies venture capital transaction
Next: 12/11/2025: FICUS HEALTH venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs